Methods of modifying amyloid β oligomers using non-peptidic compounds
US9006283B2 · kind B2 · utility
0Cited by
75References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2007 |
| Grant date | Apr 14, 2015 |
| Priority date | — |
| Expiry date | Nov 8, 2027 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2501/999
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are methods of inhibiting, regulating, and/or modulating the formation of soluble, globular, non-fibrillar, neurotoxic amyloid β1-42 oligomers from amyloid β1-42 monomers. Also disclosed are methods of treating a patient suffering from diseases associated with the formation of soluble, globular, non-fibrillar, neurotoxic amyloid β1-42 oligomers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.